APO RESEARCH · REPORT
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Product & engineering
Understand the product.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
Selected research
Industry Research
Transcatheter Aortic Valve Replacement (TAVR) Industry Research Report 2026
Market perspective
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.
Read the full market overview
In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.
Report Scope
This report quantifies the global Transcatheter Aortic Valve Replacement (TAVR) market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transcatheter Aortic Valve Replacement (TAVR).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transcatheter Aortic Valve Replacement (TAVR) Market by Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) Segment by Type
Transfemoral Approach
Transapical Approach
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Aortic Valve Replacement (TAVR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Aortic Valve Replacement (TAVR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Aortic Valve Replacement (TAVR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transfemoral Approach
- Transapical Approach
- Others
Applications
- Aortic Stenosis
- Aortic Regurgitation
- Others
Companies covered
- Edwards Lifesciences
- Medtronic
- Abbott
- Boston Scientific
- Meril Life Sciences
- Venus Medtech
- Bracco (HLT)
- JenaValve Technology
- Suzhou Jiecheng Medical Technology Co.
- Peijia Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Transcatheter Aortic Valve Replacement (TAVR) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transfemoral Approach
- 2.2.3 Transapical Approach
- 2.2.4 Others
- 2.3 Transcatheter Aortic Valve Replacement (TAVR) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Aortic Stenosis
- 2.3.3 Aortic Regurgitation
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Transcatheter Aortic Valve Replacement (TAVR) Breakdown Data by Type
- 3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Type (2021-2026)
- 3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Type (2027-2032)
4 Transcatheter Aortic Valve Replacement (TAVR) Breakdown Data by Application
- 4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Application (2021-2026)
- 4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Perspective (2021-2032)
- 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Growth Trends by Region
- 5.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Region (2021-2026)
- 5.2.3 Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Region (2027-2032)
- 5.3 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
- 5.3.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
- 5.3.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
- 5.3.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
- 5.3.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue
- 6.1.1 Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue (2021-2026)
- 6.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2021-2026)
- 6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Transcatheter Aortic Valve Replacement (TAVR) Head Office and Area Served
- 6.4 Global Transcatheter Aortic Valve Replacement (TAVR) Players, Product Type & Application
- 6.5 Global Transcatheter Aortic Valve Replacement (TAVR) Manufacturers Established Date
- 6.6 Global Transcatheter Aortic Valve Replacement (TAVR) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 7.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 7.4 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 8.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 8.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 9.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 10.2 South America Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 10.4 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size (2021-2032)
- 11.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Edwards Lifesciences
- 12.1.1 Edwards Lifesciences Company Information
- 12.1.2 Edwards Lifesciences Business Overview
- 12.1.3 Edwards Lifesciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.1.5 Edwards Lifesciences Recent Developments
- 12.2 Medtronic
- 12.2.1 Medtronic Company Information
- 12.2.2 Medtronic Business Overview
- 12.2.3 Medtronic Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.2.5 Medtronic Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Boston Scientific
- 12.4.1 Boston Scientific Company Information
- 12.4.2 Boston Scientific Business Overview
- 12.4.3 Boston Scientific Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.4.5 Boston Scientific Recent Developments
- 12.5 Meril Life Sciences
- 12.5.1 Meril Life Sciences Company Information
- 12.5.2 Meril Life Sciences Business Overview
- 12.5.3 Meril Life Sciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.5.5 Meril Life Sciences Recent Developments
- 12.6 Venus Medtech
- 12.6.1 Venus Medtech Company Information
- 12.6.2 Venus Medtech Business Overview
- 12.6.3 Venus Medtech Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.6.5 Venus Medtech Recent Developments
- 12.7 Bracco (HLT)
- 12.7.1 Bracco (HLT) Company Information
- 12.7.2 Bracco (HLT) Business Overview
- 12.7.3 Bracco (HLT) Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.7.5 Bracco (HLT) Recent Developments
- 12.8 JenaValve Technology
- 12.8.1 JenaValve Technology Company Information
- 12.8.2 JenaValve Technology Business Overview
- 12.8.3 JenaValve Technology Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.8.5 JenaValve Technology Recent Developments
- 12.9 Suzhou Jiecheng Medical Technology Co.
- 12.9.1 Suzhou Jiecheng Medical Technology Co. Company Information
- 12.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
- 12.9.3 Suzhou Jiecheng Medical Technology Co. Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
- 12.10 Peijia Medical
- 12.10.1 Peijia Medical Company Information
- 12.10.2 Peijia Medical Business Overview
- 12.10.3 Peijia Medical Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2021-2026)
- 12.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.10.5 Peijia Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst